Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38370
CAS Number:
68291-97-4
Zonisamide
Purity:
≥ 98 % (HPLC)
Synonym(s):
1,2-Benzisoxazole-3-méthanesulfonamide
Documents
$101.45 /200 mg
Taille
Request Bulk Quote
Informations sur le produit

Zonisamide is a versatile sulfonamide compound recognized for its efficacy in the treatment of epilepsy and other neurological disorders. This compound exhibits a unique mechanism of action, which includes the inhibition of voltage-gated sodium channels and the modulation of neurotransmitter release, making it a valuable option for managing seizure disorders. Its ability to cross the blood-brain barrier allows for effective therapeutic concentrations in the central nervous system, providing significant benefits for patients with refractory epilepsy.

In addition to its primary use in neurology, Zonisamide has shown potential in weight management and the treatment of mood disorders, expanding its relevance in various therapeutic areas. Researchers and healthcare professionals appreciate its favorable side effect profile compared to other antiepileptic drugs, making it a preferred choice in polytherapy settings. With ongoing studies exploring its broader applications, Zonisamide stands out as a promising compound in both clinical and research environments.

Numéro CAS 
68291-97-4
Formule moléculaire
C8H8N2O3S
Poids moléculaire 
212.22
Point de fusion 
163 - 167 °C
Informations générales
Numéro CAS 
68291-97-4
Formule moléculaire
C8H8N2O3S
Poids moléculaire 
212.22
Point de fusion 
163 - 167 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Zonisamide is widely utilized in research focused on:

  • Epilepsy Treatment: Commonly prescribed as an anticonvulsant, it helps manage seizures in patients with epilepsy, offering a valuable alternative for those who do not respond to other medications.
  • Weight Management: Research indicates its potential in weight loss therapies, as it may help reduce appetite and promote metabolic changes, making it beneficial for obesity treatment.
  • Parkinson's Disease: Studies suggest that it may have neuroprotective effects, providing a supplementary treatment option for patients suffering from Parkinson's disease.
  • Chronic Pain Management: Zonisamide is being explored for its analgesic properties, offering potential relief for patients with chronic pain conditions, enhancing their quality of life.
  • Research in Neurodegenerative Disorders: Its unique mechanism of action is being investigated for broader applications in neurodegenerative diseases, potentially leading to new therapeutic strategies.

Citations